APPLICATION
ANDA216963
TYPE
ANDA
ORIGINAL APPROVAL
2024-02-09
LATEST ACTION
2024-02-09
ROUTE
INTRAVENOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription, None (Tentative Approval)
Products
VASOPRESSIN IN DEXTROSE 5%Prescription
VASOPRESSIN 40UNITS/100ML (0.4UNITS/ML) · SOLUTION · INTRAVENOUS
VASOPRESSIN IN DEXTROSE 5%None (Tentative Approval)
VASOPRESSIN 20UNITS/100ML (0.2UNITS/ML) · SOLUTION · INTRAVENOUS
VASOPRESSINPrescription
VASOPRESSIN 20UNITS/ML (20UNITS/ML) · SOLUTION · INTRAVENOUS
Approval history
2024-02-09UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.